Amicus to sell gene therapy unit to Perceptive Advisors-backed SPAC

Amicus Therapeutics Inc has agreed to sell its gene therapy unit to ARYA Sciences Corp IV, a blank check company backed by Perceptive Advisors.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this